Although this drug is FDA-approved and has helped many individuals with their type 2 diabetes, it also has several limitations
It feels lightweight on the skin and is suitable for daily use
This is why well primarily focus on what its like to use GHK-Cu peptides in topical form
Yet, they added that, "the FDA is unable to determine how, or if, other factors may have contributed to these adverse events, such as differences in ingredients and formulation between FDA-approved and compounded semaglutide products." They also noted there was variation in the data quality in the reports they have received, which came only from 503B compounding pharmacies
Exenatide, the first of these drugs, was approved in the US for diabetes treatment in 2005
Semaglutide is the active ingredient in Ozempic (diabetes) and Wegovy (weight management)